Oral complications in cancer patients.
D000212:Acyclovir / Q000627:therapeutic use; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006560:Herpes Labialis / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D009059:Mouth Diseases / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications*
D000900:Anti-Bacterial Agents; D000666:Amphotericin B; D000212:Acyclovir